Results 61 to 70 of about 1,761 (189)

A rare case of herpes zoster triggered by a non-live varicella vaccine [PDF]

open access: yes, 2023
Herpes zoster is caused by reactivation of the latent varicella zoster virus and often occurs in immunocompromised individuals. We describe a rare case of an immunocompetent patient with herpes zoster triggered by Shingrix, a non-live vaccine designed to
Huang, William W   +5 more
core   +1 more source

Herpes Zoster Recurrence: A Narrative Review of the Literature

open access: yesDermatology and Therapy
Introduction Herpes zoster (HZ; shingles) is a painful, cutaneous disease caused by reactivation of the varicella zoster virus, which causes varicella (chickenpox) typically during childhood.
Raunak Parikh   +3 more
doaj   +1 more source

Evaluatie van het Shingrix vaccin tegen ZONA

open access: yes, 2022
Zona is een pijnlijke ziekte die veroorzaakt wordt door een reactivatie van het windpokkenvirus. In de meerderheid van de gevallen geneest zona spontaan binnen 2 à 4 weken. Maar er kunnen zich wel complicaties voordoen, zoals postherpetische neuralgie (10 à 20% van de gevallen van zona). Andere, mogelijk ernstigere, complicaties zijn zeldzamer.
Dominique, Roberfroid   +3 more
openaire   +1 more source

Herpes zoster vaccination and cognitive disorders in older adults

open access: yesAlzheimer's &Dementia, Volume 22, Issue 4, April 2026.
Abstract INTRODUCTION Previous studies suggested a reduced risk of dementia after live zoster vaccination, but were limited by short follow‐up and narrow populations. This study assessed the long‐term association between live zoster vaccination and memory disorders and Alzheimer's disease (AD) in a nationwide Korean cohort.
Jiyeon Oh   +8 more
wiley   +1 more source

Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review

open access: yesTherapeutic Advances in Vaccines and Immunotherapy, 2022
Herpes zoster (HZ) is a neurocutaneous disease that causes significant morbidity worldwide. The disease is caused by the reactivation of the varicella-zoster virus (VZV), which leads to the development of a painful, vesicular rash and can cause ...
Catherina X. Pan   +2 more
doaj   +1 more source

Baculovirus Display of Varicella–Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

open access: yesViruses, 2022
Varicella–zoster virus (VZV) is the causative agent of varicella and herpes zoster (HZ) and can pose a significant challenge to human health globally. The initial VZV infection—more common in children—causes a self-limiting chicken pox. However, in later
Wenhui Xue   +18 more
doaj   +1 more source

Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study [PDF]

open access: yes, 2020
Shingrix is poorly immunogenic following allogeneic hematopoietic cell transplantation independent of age, CD4, and B-cell recovery. In hematopoietic cell transplantation recipients with antibody response to the vaccine, varicella zoster virus ...
Natori, Yoichiro   +7 more
core   +1 more source

Non‐Specific Interstitial Pneumonia in Anti‐Jo1 Synthetase Syndrome With Probable Gougerot Syndrome: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Anti‐synthetase syndrome (ASS) is a rare autoimmune disorder of idiopathic inflammatory myopathy spectrum, characterized by the presence of aminoacyl‐tRNA synthetase antibodies, most commonly anti‐Jo‐1. Clinically presents with interstitial lung disease (ILD), myositis, and arthritis, and may be confused with other autoimmune conditions such ...
Ali Gohar   +7 more
wiley   +1 more source

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Adult Hematopoietic Cell Transplant Recipients: A Single Center Study

open access: yes, 2020
Hematopoietic cell transplant (HCT) recipients are at high risk for Varicella zoster virus (VZV) reactivation. Shingrix, the adjuvanted recombinant zoster vaccine, is a new alternative to the live-attenuated VZV vaccine for immunocompromised individuals.
Morris, Michele I   +7 more
core   +1 more source

The Squalene Oil‐in‐Water Nanoemulsion Vaccine Carrier AddaVax Potentiates TLR‐Induced B‐Cell Responses

open access: yesCytometry Part A, Volume 109, Issue 3, Page 180-191, March 2026.
ABSTRACT For vaccination, the mechanisms of action of antigens and of immunostimulatory pathogen‐associated molecular pattern (PAMP) adjuvants are better understood than the roles of the depot, carrier, and other formulation‐related influences. Here, we carried out cytometric studies of vaccine formulations and the effect of adjuvant formulations on B ...
Egest J. Pone   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy